Respiratory Infections News

The FDA has approved Fetroja for patients aged 18 years or older with hospital-acquired and ventilator-associated bacterial pneumonia, Shionogi announced.

The death toll from COVID-19 has surpassed 200,000 in the United States and could rise dramatically by the end of the year if mitigation efforts do not improve, said Jeanne M. Marrazzo, MD, MPH.

Researchers detected anti-SARS-CoV-2 IgG antibodies in the blood samples of some pediatric patients prior to viral clearance, according to a study published in The Journal of Pediatrics.

The NIH recently award $12 million to RTI International, an independent, nonprofit research institute, to support outreach and engagement efforts in ethnic and racial minority communities disproportionately impacted by the COVID-19 pandemic.

CDC Director Robert R. Redfield, MD, said surveillance shows that most people in the United States remain susceptible to COVID-19.

Johnson & Johnson announced the start of a phase 3 trial that will enroll up to 60,000 people to study the safety and efficacy of its single-dose COVID-19 vaccine candidate.

The United States has surpassed 200,000 deaths from COVID-19, according to tracking by Johns Hopkins University. If distancing measures continue to ease, the death toll could more than double by the end of 2020, a widely cited model predicted.

I just was looking for something to do during the summer hiatus after my first year in medical school. Back then, we had summers off, and students often sought medicine-related jobs to broaden their experience while earning a few dollars.

With the global COVID-19 pandemic taking research and funding precedence, other emerging infectious diseases have been seemingly placed on the back burner.

In the United States, rates of COVID-19 were 1.4 times higher than the national average in counties with higher-than-average Black and Hispanic populations, according to recent data.